ACE-inhibitor therapy, although routinely used in the treatment of hypertension and HF, does not completely block Ang-II production, and some patients can often show elevated Ang-II levels despite ACE-inhibitor therapy. This evidence concerns the gene AGT and hypertensive disorder.